| Budget Amount *help |
¥33,020,000 (Direct Cost: ¥25,400,000、Indirect Cost: ¥7,620,000)
Fiscal Year 2010: ¥10,790,000 (Direct Cost: ¥8,300,000、Indirect Cost: ¥2,490,000)
Fiscal Year 2009: ¥10,790,000 (Direct Cost: ¥8,300,000、Indirect Cost: ¥2,490,000)
Fiscal Year 2008: ¥11,440,000 (Direct Cost: ¥8,800,000、Indirect Cost: ¥2,640,000)
|
|---|
| Research Abstract |
In this study, we have developed a method to downsize the antibody by the combination of structure-design of proteins and directed evolution. We have constructed a library of alternative-binding peptide with non-immunoglobulin domain to develop molecular probe and molecular targeting drug. The helix-loop-helix peptide, which binds to specifically target molecules, is named as "MicroAntibody". We have constructed a library of MicroAntibody to generate human IgG-Fc-specific peptides and Aurora kinase-specific peptides. We also studied immunogenicity and stability of MicroAntibody
|
